MHRA Update including recall alert

MHRA Update including recall alert

January 7, 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of  Irbesartan / Hydrochlorothiazide containing products. Actavis Group PTC EHF is recalling the batches identified below from pharmacies as a precautionary measure due to possible contamination with N-nitrosodiethylamine (NDEA). Community pharmacy teams should stop supplying the above products/batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. To view the alert please visit the GOV.UK website.

Please note a new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 5 December 2018) was published in December 2018. To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.




More Latest News >

Medicine updates – January 2019

Pregabalin and gabapentin to be controlled drugs From 1 April 2019, amendments to the Misuse of Drugs Regulations 2001 and the Safe...